Gupta, Vishal Kumar, Richa Giri, and Saurabh Agrawal. “Dipeptidyl Peptidase-4 Inhibitor (teneligliptin) Significantly Reduces Liver Fat Content and Delays Progression of Non-Alcoholic Steatohepatitis in Type 2 Diabetes Mellitus Patients”. International Journal of Advances in Medicine 8, no. 12 (November 23, 2021): 1817–1820. Accessed October 13, 2025. https://www.ijmedicine.com/index.php/ijam/article/view/3257.